Země: Velká Británie
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Mycophenolate mofetil
Actavis UK Ltd
L04AA06
Mycophenolate mofetil
500mg
Tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 08020100; GTIN: 5012617018168
BBBA1802 _continued top of next column_ * Please note that ONLY Artwork Studio is permitted to make changes to the above artwork. No changes are permitted by any 3rd party other than added notes and mark ups for required changes. approved for print/date PROOF ROUND UK-Eire-Artwork-Support@accord-healthcare.com Technical Approval NON PRINTING COLOURS COLOURS DATE SENT: DATE RECEIVED: Item number: ORIGINATOR: ORIGINATION DATE: REVISION DATE: REVISED BY: DIMENSIONS: MIN BODY TEXT SIZE: SUPPLIER: 1. 2. 3. 4. 5. 6. 1. 2. 3. FMD info NA (not a carton) No Yes Details MYCOPHENOLATE MOFETIL 500MG TABLETS PIL UK Black BBBA1802 C.Grant 13/03/18 14/03/18 C.Grant 170x550mm 9pt IL/ Intas Pharmaceuti- cals, Ltd. 13/03/18 14/03/18 02 Version 2 01.11.2017 MYCOPHENOLATE MOFETIL 500MG TABLETS _continued over page_ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 WHAT MYCOPHENOLATE MOFETIL TABLETS ARE AND WHAT THEY ARE USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE MYCOPHENOLATE MOFETIL TABLETS 3 HOW TO TAKE MYCOPHENOLATE MOFETIL TABLETS 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE MYCOPHENOLATE MOFETIL TABLETS 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1 WHAT MYCOPHENOLATE MOFETIL TABLETS ARE AND WHAT THEY ARE USED FOR Mycophenolate mofetil tablets contain mycophenolate mofetil. • This belongs to a group of medicines called “immunosuppressants”. Mycophenolate mofetil tablets are used to prevent your body rejecting a transplanted organ. • A kidney, heart or liver. Mycophenolate mofetil is used to Přečtěte si celý dokument
OBJECT 1 MYCOPHENOLATE MOFETIL 500MG TABLETS Summary of Product Characteristics Updated 21-May-2018 | Accord-UK Ltd • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Mycophenolate mofetil 500mg Tablets 2. Qualitative and quantitative composition Each film-coated tablet contains 500mg mycophenolate mofetil. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet Purple coloured capsule shaped, biconvex film coated tablet, engraved 'AHI' on one side and '500' on the other, 18.0 mm in length, 9.0 mm in width and 7.00 mm in thickness. 4. Clinical particulars 4.1 Therapeutic indications Mycophenolate mofetil 500mg Tablets are indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. 4.2 Posology and method of administration Treatment with Mycophenolate mofetil 500mg Tablets should be initiated and maintained by appropr Přečtěte si celý dokument